Besides, a recent study showed that ADAM17 knockdown inhibited the expression of TGF-β in gastric carcinoma cells, with the downstream Smad2 and Smad3 also being attenuated (Xu M. et al., 2016b). Here, SMAD2 is linked to gastric carcinoma.